Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 19Head & Neck 17Thoracic 3Tumor-Agnostic 2Gynecologic 2Other solid neoplasm 1Lymphoid 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Carcinoma, Squamous Cell 1Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × nedaplatin × Thoracic × Clear all
NCT05648071 2022-12-13

SPBPDC

Qianfoshan Hospital

Phase 3 Unknown
60 enrolled
Thoracic

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT02643407 2015-12-31

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

Guangdong Association of Clinical Trials

Phase 3 Unknown
488 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT01201044 2010-09-14

DO201001

Third Military Medical University

Phase NA Unknown
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡